Search, analyze & compare

My selected companies

Adjust valuation method
WatchlistNameTickerP/EP/SP/BEV/EbitdaROEROICRSISMA200DCFVolumeClosing price
-
Bio-Rad Laboratories IncBIO-12.313.711.2817.23-9.79%-10.29%61.91$336.40$1,010.288,340$342.87

Detail of Bio-Rad Laboratories Inc

 
CEO
Mr. Norman D. Schwartz
Employees
7700
Industry
Medical Devices
Sector
Healthcare
Market cap
$10B

Company details

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Revenue
Cost of goods
Gross profit
OE
R&D
G&A
OI
OIE
PI
TAX
NI
Revenue (Rev)
$2.58B
Cost of goods (CoG)
-$1.18B
Gross profit (GP)
$1.40B
Operating expense (OE)
-$1.10B
Research and development (R&D)
-$280.18M
General and administrative (G&A)
-$817.19M
Operating income (OI)
$305.99M
Other income expense (OIE)
-$1.35B
Pretax income (PI)
-$1.01B
Tax (TAX)
$226.50M
Net income (NI)
-$778.69M
Bio-Rad Laboratories Inc
BIO • XNYS • US
$342.87
+23.38 (7.32%)
Stock vs Industry average
  • Industry average

Negative values are hidden from the graph.
Trailing annual dividend rate
$0.00
Payout ratio
0.00%
EPS
-$27.86
Margin profit
-30.18%
52 week low
$263.970001
52 week high
$376.665009
50-day simple moving average
$341.76
200-day simple moving average
$336.40
Percent held by insiders
15.58%
Percent held by institutions
80.14%
Dividend yield
0.00%

Change of shares

Cash vs Debt

Insider Trading

Comparison of selected companies

 
%
Price change
BIO +6.94%
eps change
BIO +540.27%